Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Concomitant Radiotherapy and Erlotinib in advanced lung cancer

Trial Profile

Concomitant Radiotherapy and Erlotinib in advanced lung cancer

Phase of Trial: Phase II

Latest Information Update: 04 Sep 2018

At a glance

  • Drugs Erlotinib (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms ThoRaT
  • Most Recent Events

    • 25 Aug 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
    • 04 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top